Evidence map›Paper›PMID 36497110›Full record

ArticleCells2022

Zikai Chen, Yifu Wei, Yuzhong Zheng, Hui Zhu, Qian Teng, Xianglan Lin, Fengnian Wu, Fei Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Research in pharmaceutical sciences · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Dysregulated genes in HIGK-treatedMolecular biology research communications · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zikai ChenDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Yifu WeiDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Yuzhong ZhengDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Hui ZhuDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Qian TengDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.ORCID 0000-0002-3967-1587
Xianglan LinDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Fengnian WuDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Fei ZhouDepartment of Cell Biology, Hanshan Normal University, Chaozhou 521041, China.
Hanshan Normal University · CN

Funding

Climbing Program pdjh2022b0334Doctor's Start-up Project of Hanshan Normal University QD202121Guangdong Provincial Key Laboratory of Functional Substances in Medicinal Edible Resources and Healthcare Products 2021B1212040015Project of the Educational Commission of Guangdong Province of China 2019KQNCX080, 2021ZDZX2066
6 · The paper itself

Abstract

Esophageal cancer is a lethal disease that frequently occurs in developing countries, the incidence of which could be declined by drinking EGCG-enriched drinks or food.

Indexed as

ApoptosisEsophageal NeoplasmsIntracellular Signaling Peptides and ProteinsCatechinCell Line, TumorCell MovementGenes, Tumor SuppressorHumansNF-kappa BCatechinepigallocatechin gallateIntracellular Signaling Peptides and ProteinsNF-kappa BSERPINB2 protein, humanapoptosisEGCGesophageal cancerSERPINB2

Identifiers

PMID36497110
PMCPMC9738437
OpenAlexW4310387975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.